{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T03:05:24Z","timestamp":1772507124220,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002543","name":"Pusan National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s43440-022-00441-5","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T05:08:55Z","timestamp":1670821735000},"page":"211-221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chloroquine prevents hypoxic accumulation of HIF-1\u03b1 by inhibiting ATR kinase: implication in chloroquine-mediated chemosensitization of colon carcinoma cells under hypoxia"],"prefix":"10.1007","volume":"75","author":[{"given":"Changyu","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanghyun","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaejeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4794-483X","authenticated-orcid":false,"given":"Yunjin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"441_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.semcancer.2021.10.002","volume":"85","author":"M Ivan","year":"2021","unstructured":"Ivan M, Fishel ML, Tudoran OM, Pollok KE, Wu X, Smith PJ. Hypoxia signaling: challenges and opportunities for cancer therapy. Semin Cancer Biol. 2021;85:185\u201395.","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"441_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1134\/S0006297921100011","volume":"86","author":"DS Dzhalilova","year":"2021","unstructured":"Dzhalilova DS, Makarova OV. HIF-dependent mechanisms of relationship between hypoxia tolerance and tumor development. Biochemistry (Mosc). 2021;86(10):1163\u201380.","journal-title":"Biochemistry (Mosc)"},{"issue":"14","key":"441_CR3","doi-asserted-by":"publisher","first-page":"7987","DOI":"10.1073\/pnas.95.14.7987","volume":"95","author":"LE Huang","year":"1998","unstructured":"Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA. 1998;95(14):7987\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5545","key":"441_CR4","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1126\/science.1066373","volume":"294","author":"RK Bruick","year":"2001","unstructured":"Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001;294(5545):1337\u201340.","journal-title":"Science"},{"issue":"5516","key":"441_CR5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001;292(5516):464\u20138.","journal-title":"Science"},{"issue":"5516","key":"441_CR6","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292(5516):468\u201372.","journal-title":"Science"},{"issue":"5","key":"441_CR7","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0959-437X(98)80016-6","volume":"8","author":"GL Semenza","year":"1998","unstructured":"Semenza GL. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev. 1998;8(5):588\u201394.","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"441_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2015.06.005","volume":"366","author":"GP Nagaraju","year":"2015","unstructured":"Nagaraju GP, Bramhachari PV, Raghu G, El-Rayes BF. Hypoxia inducible factor-1alpha: its role in colorectal carcinogenesis and metastasis. Cancer Lett. 2015;366(1):11\u20138.","journal-title":"Cancer Lett"},{"issue":"3","key":"441_CR9","first-page":"680","volume":"20","author":"M Ioannou","year":"2015","unstructured":"Ioannou M, Paraskeva E, Baxevanidou K, Simos G, Papamichali R, Papacharalambous C, et al. HIF-1alpha in colorectal carcinoma: review of the literature. J BUON. 2015;20(3):680\u20139.","journal-title":"J BUON"},{"key":"441_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145796","volume":"798","author":"M Rashid","year":"2021","unstructured":"Rashid M, Zadeh LR, Baradaran B, Molavi O, Ghesmati Z, Sabzichi M, et al. Up-down regulation of HIF-1alpha in cancer progression. Gene. 2021;798: 145796.","journal-title":"Gene"},{"issue":"12","key":"441_CR11","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","volume":"2","author":"L Schito","year":"2016","unstructured":"Schito L, Semenza GL. Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer. 2016;2(12):758\u201370.","journal-title":"Trends Cancer"},{"issue":"1","key":"441_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157.","journal-title":"Mol Cancer"},{"key":"441_CR13","doi-asserted-by":"publisher","first-page":"100787","DOI":"10.1016\/j.drup.2021.100787","volume":"59","author":"J Kopecka","year":"2021","unstructured":"Kopecka J, Salaroglio IC, Perez-Ruiz E, Sarmento-Ribeiro AB, Saponara S, De Las RJ, et al. Hypoxia as a driver of resistance to immunotherapy. Drug Resist Updat. 2021;59:100787.","journal-title":"Drug Resist Updat"},{"issue":"6","key":"441_CR14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.2174\/15680096113139990004","volume":"13","author":"K Ghattass","year":"2013","unstructured":"Ghattass K, Assah R, El-Sabban M, Gali-Muhtasib H. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy. Curr Cancer Drug Targets. 2013;13(6):670\u201385.","journal-title":"Curr Cancer Drug Targets"},{"issue":"21","key":"441_CR15","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1038\/sj.onc.1206385","volume":"22","author":"A Unruh","year":"2003","unstructured":"Unruh A, Ressel A, Mohamed HG, Johnson RS, Nadrowitz R, Richter E, et al. The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene. 2003;22(21):3213\u201320.","journal-title":"Oncogene"},{"key":"441_CR16","first-page":"253","volume":"7","author":"SV Karakashev","year":"2015","unstructured":"Karakashev SV, Reginato MJ. Progress toward overcoming hypoxia-induced resistance to solid tumor therapy. Cancer Manag Res. 2015;7:253\u201364.","journal-title":"Cancer Manag Res"},{"key":"441_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.pharmthera.2016.04.009","volume":"164","author":"C Wigerup","year":"2016","unstructured":"Wigerup C, Pahlman S, Bexell D. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol Ther. 2016;164:152\u201369.","journal-title":"Pharmacol Ther"},{"issue":"1\u20133","key":"441_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ejphar.2009.06.063","volume":"625","author":"VR Solomon","year":"2009","unstructured":"Solomon VR, Lee H. Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol. 2009;625(1\u20133):220\u201333.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"441_CR19","doi-asserted-by":"publisher","first-page":"e0256320","DOI":"10.1371\/journal.pone.0256320","volume":"16","author":"YR Fauzi","year":"2021","unstructured":"Fauzi YR, Nakahata S, Chilmi S, Ichikawa T, Nueangphuet P, Yamaguchi R, et al. Antitumor effects of chloroquine\/hydroxychloroquine mediated by inhibition of the NF-kappaB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia\/lymphoma cells. PLoS ONE. 2021;16(8):e0256320.","journal-title":"PLoS ONE"},{"key":"441_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejps.2019.04.011","volume":"134","author":"NM Kocaturk","year":"2019","unstructured":"Kocaturk NM, Akkoc Y, Kig C, Bayraktar O, Gozuacik D, Kutlu O. Autophagy as a molecular target for cancer treatment. Eur J Pharm Sci. 2019;134:116\u201337.","journal-title":"Eur J Pharm Sci"},{"key":"441_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105582","volume":"168","author":"PMP Ferreira","year":"2021","unstructured":"Ferreira PMP, Sousa RWR, Ferreira JRO, Militao GCG, Bezerra DP. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms. Pharmacol Res. 2021;168: 105582.","journal-title":"Pharmacol Res"},{"issue":"2","key":"441_CR22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4161\/auto.8.2.18554","volume":"8","author":"P Maycotte","year":"2012","unstructured":"Maycotte P, Aryal S, Cummings CT, Thorburn J, Morgan MJ, Thorburn A. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy. 2012;8(2):200\u201312.","journal-title":"Autophagy"},{"issue":"11","key":"441_CR23","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3390\/ph14111092","volume":"14","author":"S Jeong","year":"2021","unstructured":"Jeong S, Kang C, Park S, Ju S, Yoo JW, Yoon IS, et al. Eletrophilic chemistry of tranilast is involved in its anti-colitic activity via Nrf2-HO-1 pathway activation. Pharmaceuticals (Basel). 2021;14(11):1092.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"441_CR24","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3390\/cells9061363","volume":"9","author":"Y Lee","year":"2020","unstructured":"Lee Y, Kim SJ, Choo J, Heo G, Yoo J-W, Jung Y, et al. miR-23a-3p is a key regulator of IL-17C-induced tumor angiogenesis in colorectal cancer. Cells. 2020;9(6):1363.","journal-title":"Cells"},{"issue":"5","key":"441_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","volume":"5","author":"GN Masoud","year":"2015","unstructured":"Masoud GN, Li W. HIF-1alpha pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin B. 2015;5(5):378\u201389.","journal-title":"Acta Pharm Sin B"},{"issue":"Pt 11","key":"441_CR26","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1242\/jcs.078030","volume":"124","author":"F Bouquet","year":"2011","unstructured":"Bouquet F, Ousset M, Biard D, Fallone F, Dauvillier S, Frit P, et al. A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia. J Cell Sci. 2011;124(Pt 11):1943\u201351.","journal-title":"J Cell Sci"},{"issue":"37","key":"441_CR27","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1038\/onc.2012.462","volume":"32","author":"F Fallone","year":"2013","unstructured":"Fallone F, Britton S, Nieto L, Salles B, Muller C. ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression. Oncogene. 2013;32(37):4387\u201396.","journal-title":"Oncogene"},{"issue":"11","key":"441_CR28","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.4161\/cbt.21093","volume":"13","author":"R Prevo","year":"2012","unstructured":"Prevo R, Fokas E, Reaper PM, Charlton PA, Pollard JR, McKenna WG, et al. The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy. Cancer Biol Ther. 2012;13(11):1072\u201381.","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"441_CR29","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1158\/1535-7163.MCT-12-0902","volume":"12","author":"Y Dai","year":"2013","unstructured":"Dai Y, Chen S, Kmieciak M, Zhou L, Lin H, Pei XY, et al. The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair. Mol Cancer Ther. 2013;12(6):878\u201389.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"441_CR30","first-page":"799","volume":"14","author":"N Damjanov","year":"2000","unstructured":"Damjanov N, Meropol NJ. Oral therapy for colorectal cancer: how to choose. Oncology (Williston Park). 2000;14(6):799\u2013807 (discussion 807\u20138, 813\u20134).","journal-title":"Oncology (Williston Park)"},{"issue":"5","key":"441_CR31","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.7314\/APJCP.2015.16.5.2031","volume":"16","author":"S Thongchot","year":"2015","unstructured":"Thongchot S, Loilome W, Yongvanit P, Dokduang H, Thanan R, Techasen A, et al. Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells. Asian Pac J Cancer Prev. 2015;16(5):2031\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"441_CR32","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.bbrc.2012.12.052","volume":"430","author":"ZW Yan","year":"2013","unstructured":"Yan ZW, Hou JK, He W, Fan L, Huang Y. Chloroquine enhances cobalt chloride-induced leukemic cell differentiation via the suppression of autophagy at the late phase. Biochem Biophys Res Commun. 2013;430(3):926\u201332.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"441_CR33","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3892\/mmr.2014.2839","volume":"11","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Li Y, Li Y, Li R, Ma Y, Wang H, et al. Chloroquine inhibits MGC803 gastric cancer cell migration via the Toll-like receptor 9\/nuclear factor kappa B signaling pathway. Mol Med Rep. 2015;11(2):1366\u201371.","journal-title":"Mol Med Rep"},{"issue":"4","key":"441_CR34","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/jat.3749","volume":"39","author":"J Munoz-Sanchez","year":"2019","unstructured":"Munoz-Sanchez J, Chanez-Cardenas ME. The use of cobalt chloride as a chemical hypoxia model. J Appl Toxicol. 2019;39(4):556\u201370.","journal-title":"J Appl Toxicol"},{"key":"441_CR35","doi-asserted-by":"publisher","first-page":"10703","DOI":"10.1074\/jbc.M112.414771","volume":"288","author":"M Hubbi","year":"2013","unstructured":"Hubbi M, Hu H, Kshitiz Ahmed I, Levchenko A, Semenza GL. Chaperone-mediated autophagy targets hypoxia-inducible factor-1alpha (HIF-1alpha) for lysosomal degradation. J Biol Chem. 2013;288:10703\u201314.","journal-title":"J Biol Chem"},{"issue":"22","key":"441_CR36","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1111\/bph.13990","volume":"174","author":"K Wu","year":"2017","unstructured":"Wu K, Zhang Q, Wu X, Lu W, Tang H, Liang Z, et al. Chloroquine is a potent pulmonary vasodilator that attenuates hypoxia-induced pulmonary hypertension. Br J Pharmacol. 2017;174(22):4155\u201372.","journal-title":"Br J Pharmacol"},{"issue":"33","key":"441_CR37","doi-asserted-by":"publisher","first-page":"25867","DOI":"10.1074\/jbc.M110.135632","volume":"285","author":"HJ Jung","year":"2010","unstructured":"Jung HJ, Kim JH, Shim JS, Kwon HJ. A novel Ca2+\/calmodulin antagonist HBC inhibits angiogenesis and down-regulates hypoxia-inducible factor. J Biol Chem. 2010;285(33):25867\u201374.","journal-title":"J Biol Chem"},{"issue":"5","key":"441_CR38","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001636RRR","volume":"35","author":"Z Li","year":"2021","unstructured":"Li Z, Wang-Heaton H, Cartwright BM, Makinwa Y, Hilton BA, Musich PR, et al. ATR prevents Ca2+ overload-induced necrotic cell death through phosphorylation-mediated inactivation of PARP1 without DNA damage signaling. The FASEB J. 2021;35(5): e21373.","journal-title":"The FASEB J"},{"issue":"5","key":"441_CR39","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1091\/mbc.02-02-0017","volume":"13","author":"KJ Lang","year":"2002","unstructured":"Lang KJ, Kappel A, Goodall GJ. Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol Biol Cell. 2002;13(5):1792\u2013801.","journal-title":"Mol Biol Cell"},{"key":"441_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-1-61779-430-8_4","volume":"821","author":"DD Vadysirisack","year":"2012","unstructured":"Vadysirisack DD, Ellisen LW. mTOR activity under hypoxia. Methods Mol Biol. 2012;821:45\u201358.","journal-title":"Methods Mol Biol"},{"issue":"4","key":"441_CR41","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1158\/1541-7786.MCR-17-0696","volume":"16","author":"M Ding","year":"2018","unstructured":"Ding M, Van der Kwast TH, Vellanki RN, Foltz WD, McKee TD, Sonenberg N, et al. The mTOR targets 4E-BP1\/2 restrain tumor growth and promote hypoxia tolerance in PTEN-driven prostate cancer. Mol Cancer Res. 2018;16(4):682\u201395.","journal-title":"Mol Cancer Res"},{"issue":"6922","key":"441_CR42","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nature01368","volume":"421","author":"CJ Bakkenist","year":"2003","unstructured":"Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 2003;421(6922):499\u2013506.","journal-title":"Nature"},{"key":"441_CR43","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34836","volume":"7","author":"M Qian","year":"2018","unstructured":"Qian M, Liu Z, Peng L, Tang X, Meng F, Ao Y, et al. Boosting ATM activity alleviates aging and extends lifespan in a mouse model of progeria. Elife. 2018;7: e34836.","journal-title":"Elife"},{"key":"441_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.9","volume":"2","author":"EY So","year":"2011","unstructured":"So EY, Ausman M, Saeki T, Ouchi T. Phosphorylation of SMC1 by ATR is required for desferrioxamine (DFO)-induced apoptosis. Cell Death Dis. 2011;2: e128.","journal-title":"Cell Death Dis"},{"issue":"8","key":"441_CR45","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/cbin.10463","volume":"39","author":"Y Fang","year":"2015","unstructured":"Fang Y, Tan J, Zhang Q. Signaling pathways and mechanisms of hypoxia-induced autophagy in the animal cells. Cell Biol Int. 2015;39(8):891\u20138.","journal-title":"Cell Biol Int"},{"key":"441_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.2998","author":"Y Chen","year":"2017","unstructured":"Chen Y, Sun L, Guo D, Wu Z, Chen W. Co-delivery of hypoxia inducible factor-1alpha small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells. J Gene Med. 2017. https:\/\/doi.org\/10.1002\/jgm.2998.","journal-title":"J Gene Med"},{"issue":"3","key":"441_CR47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3727\/096504015X14500513118029","volume":"23","author":"Q Zhao","year":"2016","unstructured":"Zhao Q, Tan BB, Li Y, Fan LQ, Yang PG, Tian Y. Enhancement of drug sensitivity by knockdown of HIF-1alpha in gastric carcinoma cells. Oncol Res. 2016;23(3):129\u201336.","journal-title":"Oncol Res"},{"issue":"1","key":"441_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13046-021-02229-6","volume":"41","author":"S Dong","year":"2022","unstructured":"Dong S, Liang S, Cheng Z, Zhang X, Luo L, Li L, et al. ROS\/PI3K\/Akt and Wnt\/beta-catenin signalings activate HIF-1alpha-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer. J Exp Clin Cancer Res. 2022;41(1):15.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"441_CR49","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1158\/0008-5472.CAN-08-4910","volume":"70","author":"W Wen","year":"2010","unstructured":"Wen W, Ding J, Sun W, Wu K, Ning B, Gong W, et al. Suppression of cyclin D1 by hypoxia-inducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil-induced apoptosis of A549 cells. Cancer Res. 2010;70(5):2010\u20139.","journal-title":"Cancer Res"},{"key":"441_CR50","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.2147\/CMAR.S246272","volume":"12","author":"G Xu","year":"2020","unstructured":"Xu G, Li M, Wu J, Qin C, Tao Y, He H. Circular RNA circNRIP1 sponges microRNA-138-5p to maintain hypoxia-induced resistance to 5-fluorouracil through HIF-1alpha-dependent glucose metabolism in gastric carcinoma. Cancer Manag Res. 2020;12:2789\u2013802.","journal-title":"Cancer Manag Res"},{"issue":"2","key":"441_CR51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.oraloncology.2008.04.002","volume":"45","author":"S Yoshiba","year":"2009","unstructured":"Yoshiba S, Ito D, Nagumo T, Shirota T, Hatori M, Shintani S. Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest. Oral Oncol. 2009;45(2):109\u201315.","journal-title":"Oral Oncol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-022-00441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-022-00441-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-022-00441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T21:37:14Z","timestamp":1675287434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-022-00441-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["441"],"URL":"https:\/\/doi.org\/10.1007\/s43440-022-00441-5","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"7 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declares that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}